Cardiac
-
VitalConnect raises $100M for heart monitor patch
VitalConnect will use the money to commercialize the monitor, which detects arrhythmias and competes with patches from companies including iRhythm.
By Nick Paul Taylor • Feb. 21, 2025 -
J&J resumes PFA cases, but analysts warn safety may hamper rollout
J.P. Morgan analysts said the findings of J&J’s investigation “could significantly hinder the product’s rollout in the U.S. and globally” and lead doctors to “de-prioritize Varipulse.”
By Nick Paul Taylor • Feb. 18, 2025 -
Explore the Trendline➔
Sarah Silbiger via Getty ImagesTrendlineMedical device safety in spotlight after high profile recalls
From Philips’ massive recall of respiratory devices to ongoing health risks with breast implants, medical devices tied to patient harm have put a focus on product safety.
By MedTech Dive staff -
Edwards predicts second-half lift from TAVR label expansion
Executives expect a new label indication and a hoped-for easing of hospital capacity constraints to accelerate sales this year.
By Susan Kelly • Feb. 12, 2025 -
FDA posts early alert about BD device linked to 30 injuries, 4 deaths
The alert was posted one day after BD sent customers a letter warning about the risk of atherectomy catheters breaking.
By Nick Paul Taylor • Feb. 10, 2025 -
Pulse Biosciences names new CFO, continuing string of C-suite changes
Pulse, which named a new CEO last month, is pitching its pulsed field ablation technology as a way to shorten procedure times.
By Nick Paul Taylor • Feb. 5, 2025 -
Boston Scientific closes its year of PFA on a high note
Farapulse, Boston Scientific’s pulsed field ablation product, fueled year-over-year growth of nearly 171% in the fourth quarter for the company’s electrophysiology group.
By Ricky Zipp • Feb. 5, 2025 -
2025 outlook
Top medtech trends in 2025: New products and M&A are bright spots, but Trump brings uncertainty
Experts highlighted surgical robotics, artificial intelligence and M&A as top trends this year. However, the Trump administration could create challenges for the industry.
By Ricky Zipp • Jan. 31, 2025 -
Getinge exits surgical perfusion, creating opportunity for Livanova
Getinge CEO Mattias Perjos said surgical perfusion has “been a struggling category” since an FDA consent decree forced the company off the U.S. market in 2015.
By Nick Paul Taylor • Jan. 30, 2025 -
Neko Health raises $260M to expand body scan service, fund R&D
The company uses various medical devices to noninvasively check moles, the heart and more.
By Nick Paul Taylor • Jan. 28, 2025 -
Doctors expect Boston Scientific to lead PFA race, survey finds
Physicians also expect greater use of Johnson & Johnson’s Varipulse system over the next two years despite the company’s current pause of U.S. cases, according to a poll by BTIG.
By Susan Kelly • Jan. 27, 2025 -
Abbott expects to launch first PFA device outside of the US this year
CEO Robert Ford also plans to expand sales of the company’s Lingo over-the-counter glucose sensors after a limited rollout.
By Elise Reuter • Jan. 22, 2025 -
J&J coordinating with FDA on US pause of Varipulse due to safety risks
Johnson & Johnson executives, on a Wednesday earnings call, did not provide a timeline for when U.S. Varipulse cases will restart after halting procedures in early January.
By Ricky Zipp • Jan. 22, 2025 -
Boston Scientific study meets goals for PFA in persistent AFib
The results will support the company’s application for expanded labeling of its popular Farapulse pulsed field ablation system in a larger group of patients with atrial fibrillation.
By Susan Kelly • Jan. 21, 2025 -
JPM25 recap: Robotics, PFA and OTC glucose sensors in the spotlight
CEOs from Medtronic, Intuitive Surgical, Boston Scientific and Dexcom were on hand this week in San Francisco to discuss the year ahead at the J.P. Morgan Healthcare Conference.
By Susan Kelly • Jan. 17, 2025 -
Boston Scientific ups PFA forecast, targets market leadership
At the J.P. Morgan Healthcare Conference, Boston Scientific forecast that pulsed field ablation will be used in more than 60% of atrial fibrillation procedures globally by 2026.
By Nick Paul Taylor • Jan. 15, 2025 -
Philips recall of heart monitor software tied to 109 injuries, 2 deaths
Some electrocardiogram events, such as atrial fibrillation or abnormally rapid heartbeats, over two years were not reviewed by healthcare professionals due to a data routing issue.
By Ricky Zipp • Jan. 14, 2025 -
CEO Geoff Martha tells JPM crowd Medtronic is ‘stacking growth drivers’
New technologies for atrial fibrillation, hypertension, diabetes and neurological conditions are poised for fast growth, Martha said Monday at the J.P. Morgan Healthcare Conference.
By Susan Kelly • Jan. 14, 2025 -
CMS starts Medicare coverage analysis for Medtronic, Recor renal denervation devices
J.P. Morgan analysts said the CMS’ review “validates the technology and could potentially move the needle on growth for Medtronic.”
By Nick Paul Taylor • Jan. 14, 2025 -
Eko Health names Justin Spencer as CFO
Spencer’s arrival at Eko comes months after the digital health company appointed his former colleague Brent Lang to its board of directors.
By Nick Paul Taylor • Jan. 10, 2025 -
Retrieved from Fire1 on January 10, 2025
Fire1 raises $120M to trial heart failure management system
Medtronic and Novo Holdings were among the investors in the funding round.
By Nick Paul Taylor • Jan. 10, 2025 -
Deep Dive // 2025 outlook
5 medtech trends to watch in 2025
After a busy 2024, experts called out competition in soft tissue robotics, uncertainty from a Trump White House and continued success for pulsed field ablation as trends to watch this year.
By Ricky Zipp • Jan. 9, 2025 -
J&J pauses Varipulse PFA cases in US
The temporary halt to investigate reported neurovascular events comes two months after Johnson & Johnson won FDA approval for the pulsed field ablation system.
By Susan Kelly • Jan. 8, 2025 -
Boston Scientific to buy remaining Bolt Medical stake for up to $664M
The deal for Bolt, developer of an intravascular lithotripsy system to treat coronary and peripheral artery disease, continues Boston Scientific’s brisk run of acquisitions.
By Susan Kelly • Jan. 8, 2025 -
Top 10 medtech deals of 2024
Multibillion-dollar buyouts returned last year, led by Johnson & Johnson’s $13.1 billion acquisition of Shockwave Medical.
By Nick Paul Taylor • Jan. 2, 2025 -
CMS proposes Medicare coverage for transcatheter tricuspid replacement
Edwards submitted a request for a national coverage determination in February, after receiving FDA approval for its Evoque device earlier that month.
By Elise Reuter • Updated Dec. 23, 2024